Discontinuation report RANITIDINE INJECTION USP

Last updated on 2020-11-03 History
Report ID 127684
Drug Identification Number 02256711
Brand name RANITIDINE INJECTION USP
Common or Proper name RANITIDINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RANITIDINE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 VIALS OF 2ML
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2020-11-02
Remaining supply date 2020-11-02
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments PrFamotidine Omega 10mg/mL as a substitute for PrRanitidine Injection USP 25 mg/mL
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-11-03 English Compare
v2 2020-11-02 French Compare
v1 2020-11-02 English Compare